サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：RNA標的低分子創薬市場：適応症別、薬剤別、投与経路別、エンドユーザー別、国別、地域別：産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1339884

RNA標的低分子創薬市場：適応症別、薬剤別、投与経路別、エンドユーザー別、国別、地域別：産業分析、市場規模、市場シェア、2023-2030年予測

RNA Targeting Small Molecule Drug Discovery Market with COVID-19 Impact Analysis, By Indication, By Drug, By Route of Administration, By End-user, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 311 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.94円
RNA標的低分子創薬市場：適応症別、薬剤別、投与経路別、エンドユーザー別、国別、地域別：産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年08月01日
発行: AnalystView Market Insights
ページ情報: 英文 311 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

RNAターゲティング低分子創薬市場規模は2022年に12億810万米ドルとなり、2023年から2030年にかけてCAGR 21.8%で拡大

RNA標的低分子創薬市場-市場力学：

  • いくつかの新しい技術とヘルスケア分野が市場の需要を高めています。
  • RNA分子の薬剤能力を拡大するために、様々な新規技術が開発されています。その結果、現在および新規のRNA標的に作用する可能性のある数多くの低分子が、感染症、遺伝病、その他の種類のがんを含むいくつかの適応症の治療のために、前臨床試験および臨床試験で研究されています。従って、このような要因がRNA標的低分子創薬市場の需要を押し上げる可能性があります。しかし、薬物研究にかかる法外なコストが市場成長の主な障害の一つとなっています。さらに、RNA標的低分子創薬産業は、現在のヘルスケア部門が様々な疾患を治療する方法を変革する可能性があると予測されています。これに伴い、これらの薬剤は、遺伝子発現を制御するために重要であるため薬剤開発にとって魅力的なターゲットであるRNA分子を選択的に標的とすることで機能します。

RNA標的低分子創薬市場-セグメンテーション分析：

  • 世界のRNA標的低分子創薬市場は、適応症、薬剤、投与経路、エンドユーザー、地域に基づいてセグメント化されます。
  • 適応症は、神経疾患、がん、代謝性疾患、感染症、その他の4つに分類されます。市場の大半を占めるのはがん領域です。RNA標的薬は、がん細胞のみを標的とし、がんに関連する遺伝子変化を特異的に標的とするように作成されているため、有効性と副作用の軽減という点で、他のタイプのがん治療薬と比較して最先端を行く。さらに、がん治療のために様々な製薬会社がRNA標的薬の創薬に多額の投資を行っており、これが市場の成長を促進すると思われます。
  • 市場は薬剤によって6つのカテゴリーに分類される：tomivosertib、translarna、risdiplam、ELX-02、ABX464、H3B-6545。translarna（TM）セグメントは最大の売上シェアを占めると予想されています。トランスラーナ（TM）は、ナンセンス変異として知られる特定のタイプの変異によって引き起こされる遺伝性疾患を治療するために開発されました。さらに、これらの変異は、ある種の嚢胞性線維症や筋ジストロフィーなど、いくつかの遺伝性疾患につながる可能性があります。さらに、トランスラーナ（TM）はmRNAにおいて、早発停止コドンの"リードスルー"を促進し、リボソームが翻訳を続け、完全長で機能的なタンパク質を作り出すことを可能にします。これにより、ナンセンス変異による遺伝的障害の影響が緩和される可能性があります。
  • 市場は投与経路によって皮下投与と経口投与の2つに区分されます。経口剤が最も大きな売上シェアを占めると思われます。経口投与は、患者のコンプライアンスと利便性の高さから、ドラッグデリバリーにおいて最も好まれる経路のひとつです。経口投与によって低分子薬剤を容易に投与できること、侵襲的な処置を回避できること、治療レジメンに対する患者のアドヒアランスが向上する可能性があることなどが、低分子薬剤の経口投与システムを開発する利点です。
  • 市場はエンドユーザーによって、学術・研究機関、製薬・バイオ製薬企業、その他の2つのカテゴリーに分けられます。製薬・バイオ製薬企業セグメントは、予測期間中も優位性を維持しそうです。彼らは創薬に関して膨大な経験とリソースを有しており、その結果、このセグメントは引き続き市場を独占すると予想されます。市場には、様々な中小規模のバイオ医薬品セクターが進出しています。

RNA標的低分子創薬市場-地理的洞察：

地理的には、北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。

RNA標的低分子創薬市場-競合情勢：

競争の激しいRNA標的低分子創薬業界では、さまざまな業界が市場の覇権を争っています。これらの業界は、RNA標的医薬品の生産と開発におけるリソースと経験に基づいて、市場で大きな存在感を示しています。さらに、新しい治療法を導入し、規制当局の許可を得るために、規制当局やヘルスケアプロバイダーとのコネクションを構築しています。例えば、2023年2月、ReviR Therapeutics社はAsieris社と提携し、新たながん治療薬を開発しました。さらに、泌尿生殖器腫瘍やその他の関連する重篤な疾患に対する新たな治療法を開発することも、この提携の目的です。

目次

第1章 RNAターゲティング低分子創薬市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 RNAターゲティング低分子創薬の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 RNAをターゲットとした低分子創薬産業の研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 RNA標的低分子創薬市場：COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 RNA標的低分子創薬市場情勢

  • RNAターゲティング低分子創薬市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 RNA標的低分子創薬市場- 適応症別

  • 概要
    • 適応症別セグメントシェア分析
    • 神経疾患
    • がん
    • 代謝性疾患
    • 感染症
    • その他

第8章 低分子創薬市場をターゲットとしたRNA-薬剤別

  • 概要
    • 医薬品別セグメントシェア分析
    • トミボセルチブ
    • トランスラーナ（TM）
    • リスディプラム
    • ELX-02
    • ABX464
    • H3B-6545

第9章 RNA標的低分子創薬市場- 投与経路別

  • 概要
    • 投与経路別セグメントシェア分析
    • 皮下
    • オーラル

第10章 RNA標的低分子創薬市場- エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 学術調査機関
    • 製薬会社およびバイオ医薬品会社
    • その他

第11章 RNA標的低分子創薬市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- 低分子創薬産業をターゲットとしたRNA

  • 競合ダッシュボード
  • 企業プロファイル
    • PTC Therapeutics
    • Accent Therapeutics
    • Expansion Therapeutics
    • Anima Biotech Inc.
    • Servier Laboratories
    • Arrakis Therapeutics
    • AstraZeneca
    • Skyhawk Therapeutics, Inc.
    • Epics Therapeutics
    • H3 Biomedicine Inc.
    • Hoffmann-La Roche Ltd
    • Ribometrix
    • AC immune
    • STORM Therapeutics

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE RNA Targeting Small Molecule Drug Discovery Market: Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global RNA Targeting Small Molecule Drug Discovery Market, by Indication2018-2030 (USD Million)
  • TABLE RNA Targeting Small Molecule Drug Discovery Market: DrugSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug
  • TABLE Global RNA Targeting Small Molecule Drug Discovery Market, by Drug2018-2030 (USD Million)
  • TABLE RNA Targeting Small Molecule Drug Discovery Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE RNA Targeting Small Molecule Drug Discovery Market: End-user Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-user
  • TABLE Global RNA Targeting Small Molecule Drug Discovery Market, by End-user 2018-2030 (USD Million)
  • TABLE RNA Targeting Small Molecule Drug Discovery Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global RNA Targeting Small Molecule Drug Discovery Market, by Region 2018-2030 (USD Million)
  • TABLE North America RNA Targeting Small Molecule Drug Discovery Market, by Country, 2018-2030 (USD Million)
  • TABLE North America RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2018-2030 (USD Million)
  • TABLE North America RNA Targeting Small Molecule Drug Discovery Market, by Drug, 2018-2030 (USD Million)
  • TABLE North America RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America RNA Targeting Small Molecule Drug Discovery Market, by End-user, 2018-2030 (USD Million)
  • TABLE Europe RNA Targeting Small Molecule Drug Discovery Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2018-2030 (USD Million)
  • TABLE Europe RNA Targeting Small Molecule Drug Discovery Market, by Drug, 2018-2030 (USD Million)
  • TABLE Europe RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe RNA Targeting Small Molecule Drug Discovery Market, by End-user, 2018-2030 (USD Million)
  • TABLE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by Drug, 2018-2030 (USD Million)
  • TABLE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by End-user, 2018-2030 (USD Million)
  • TABLE Latin America RNA Targeting Small Molecule Drug Discovery Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2018-2030 (USD Million)
  • TABLE Latin America RNA Targeting Small Molecule Drug Discovery Market, by Drug, 2018-2030 (USD Million)
  • TABLE Latin America RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America RNA Targeting Small Molecule Drug Discovery Market, by End-user, 2018-2030 (USD Million)
  • TABLE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market, by Drug, 2018-2030 (USD Million)
  • TABLE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market, by End-user, 2018-2030 (USD Million)

List of Figures

  • FIGURE RNA Targeting Small Molecule Drug Discovery Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Indication segment market share analysis, 2022&2030
  • FIGURE Indication segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Drug segment market share analysis, 2022&2030
  • FIGURE Drug segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2022&2030
  • FIGURE Route of Administrationsegment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-user segment market share analysis, 2022&2030
  • FIGURE End-user segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America RNA Targeting Small Molecule Drug Discovery Market share and leading players, 2022
  • FIGURE Europe RNA Targeting Small Molecule Drug Discovery Market share and leading players, 2022
  • FIGURE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market share and leading players, 2022
  • FIGURE Latin America RNA Targeting Small Molecule Drug Discovery Market share and leading players, 2022
  • FIGURE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe RNA Targeting Small Molecule Drug Discovery Market share analysis by country, 2022
  • FIGURE Germany RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market share analysis by country, 2022
  • FIGURE India RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America RNA Targeting Small Molecule Drug Discovery Market share analysis by country, 2022
  • FIGURE Brazil RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market share analysis by country, 2022
  • FIGURE Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1608

REPORT HIGHLIGHT

RNA targeting small molecule drug discovery Market size was valued at USD 1,208.1 Million in 2022, expanding at a CAGR of 21.8% from 2023 to 2030.

RNA targeting small molecules drug discovery refers to the process of examining and developing small molecule drugs that specifically inhibit and modulate the function of RNA molecules within cells. RNA, or ribonucleic acid, plays an essential role in several cellular processes, including regulation and gene expression. Moreover, a tiny molecule is an organic compound with a relatively low, molecular weight that can interact with biological targets including nucleic acids or proteins.

RNA Targeting Small Molecule Drug Discovery Market- Market Dynamics:

  • Several novel techniques and the healthcare sector raising the market demand.
  • To expand the drug ability of RNA molecules various novel techniques have been developed. As a result, numerous small molecules, with the potential of acting on current and novel RNA targets are also being studied in preclinical and clinical studies for the treatment of several indications, including infectious diseases, genetic diseases, and other types of cancers. Thus, such factors may drive the demand for the RNA targeting small molecules drug discovery market. However, the exorbitant cost of medication research is one of the main obstacles to the market growth. Moreover, it is projected that the RNA targeting small molecules drug discovery industry could transform the way the healthcare sector currently treats various diseases. In line with this, these drugs function by selectively targeting RNA molecules, which are appealing targets for drug development as they are important for controlling gene expression.

RNA Targeting Small Molecule Drug Discovery Market- Key Insights:

  • As per the analysis shared by our research analyst, the global RNA targeting small molecule drug discovery market is estimated to grow annually at a CAGR of around 21.8% over the forecast period (2023-2030)
  • This market pioneers the development of drugs that selectively target RNA, presenting a promising approach to tackle diseases with unmet medical needs, such as genetic disorders and certain cancers.
  • RNA-targeted small molecules offer new dimensions to drug discovery, complementing traditional approaches and broadening the scope of treatable conditions, ultimately improving patient outcomes.
  • On the basis of region, North America was the leading revenue generator in 2022

RNA Targeting Small Molecule Drug Discovery Market- Segmentation Analysis:

  • The global RNA targeting small molecule drug discovery market is segmented on the basis of indication, drug, route of administration, end-user, and region.
  • The market is divided into four categories based on indication: neurological diseases, cancer, metabolic diseases, infectious disease, and others. The cancer segment is accounted to dominate the market. As they target cancer cells only and are created to specifically target cancer-related genetic alterations, RNA-targeted drugs have a cutting-edge as compared to other types of cancer treatments in terms of efficacy and side effects reduction. Moreover, for cancer treatment various pharmaceutical companies are investing heavily in RNA-targeted drug discovery, which is likely to fuel the market growth.
  • The market is categorized into six categories based on the drug: tomivosertib, translarna, risdiplam, ELX-02, ABX464, and H3B-6545. The translarna™ segment is expected to witness the largest revenue share. It is created to treat genetic disorders caused by a particular type of mutation known as a nonsense mutation. Additionally, these mutations can lead to several genetic disorders such as certain types of cystic fibrosis and muscular dystrophy. Moreover, in the mRNA Translarna™ promotes "read-through" of the premature stop codon, allowing the ribosome to continue translating and create a full-length, functional protein. This might mitigate the effects of the genetic disorder caused by the nonsense mutation.
  • The market is segmented into two categories based on the route of administration: subcutaneous and oral. The oral segment is likely to possess the largest revenue share. As it is one of the crucial preferred routes for drug delivery owing to its patient compliance and convenience. The capability to administer small molecule medications easily by oral route, avoidance of invasive procedures, and potentially improved patient adherence to treatment regimens are the advantages of developing oral delivery systems for small molecule medications.
  • The market is divided into two categories based on end-user: academic and research institutes, pharmaceutical and biopharmaceutical companies, and others. The pharmaceutical and biopharmaceutical companies segment is likely to maintain its dominance over the forecast period. As they have huge experience and resources in terms of drug discovery, and as a result, the segment is expected to continue to dominate the market. There are various small to medium-sized biopharmaceutical sectors penetrating the market.

RNA Targeting Small Molecule Drug Discovery Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

RNA Targeting Small Molecule Drug Discovery Market- Competitive Landscape:

In the competitive RNA-targeting small molecule drug discovery industry, various industries are contending for market dominance. These industries have a substantial presence on the market, based on their resources and experience in the production and development of RNA-targeted pharmaceuticals. Moreover, to introduce new treatments and get regulatory permission, they have developed connections with regulatory organizations and healthcare providers. For instance, in February 2023, ReviR Therapeutics collaborated with Asieris to develop new oncology therapies. Additionally, developing new treatments for genitourinary tumors and other related serious diseases is the aim of this collaboration.

Recent Developments:

For instance, in January 2023, Atomic AI released a $35 million series for the advancement of an AI-driven RNA structure platform for the treatment of incurable diseases.

Key features of the study:

  • This proposed research study on RNA targeting small molecule drug discovery market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
  • The report provides the client the latest up-to-date and trending insights about the RNA targeting small molecule drug discovery market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for RNA targeting small molecule drug discovery market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the RNA targeting small molecule drug discovery market.
  • Impact of COVID-19 on RNA targeting small molecule drug discovery market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on RNA targeting small molecule drug discovery market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the RNA targeting small molecule drug discovery market, we have also included competitive landscape and key innovator analysis for the RNA targeting small molecule drug discovery market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the RNA targeting small molecule drug discovery market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global RNA targeting small molecule drug discovery market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET KEY PLAYERS

  • PTC Therapeutics
  • Accent Therapeutics
  • Expansion Therapeutics
  • Anima Biotech Inc.
  • Servier Laboratories
  • Arrakis Therapeutics
  • AstraZeneca
  • Skyhawk Therapeutics, Inc.
  • Epics Therapeutics
  • H3 Biomedicine Inc.
  • Hoffmann-La Roche Ltd
  • Ribometrix
  • AC immune
  • STORM Therapeutics

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY INDICATION

  • Neurological Diseases
  • Cancer
  • Metabolic Diseases
  • Infectious Disease
  • Others

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY DRUG

  • Tomivosertib
  • Translarna
  • Risdiplam
  • ELX-02
  • ABX464
  • H3B-6545

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY ROUTE OF ADMINISTRATION

  • Subcutaneous
  • Oral
  • Others

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY END-USER

  • Academic and Research Institutes
  • Pharmaceutical and Biopharmaceutical Companies
  • Others

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. RNA Targeting Small Molecule Drug Discovery Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. RNA Targeting Small Molecule Drug Discovery Market Snippet by Indication
    • 2.1.2. RNA Targeting Small Molecule Drug Discovery Market Snippet by Drug
    • 2.1.3. RNA Targeting Small Molecule Drug Discovery Market Snippet by Route of Administration
    • 2.1.4. RNA Targeting Small Molecule Drug Discovery Market Snippet by End-user
    • 2.1.5. RNA Targeting Small Molecule Drug Discovery Market Snippet by Country
    • 2.1.6. RNA Targeting Small Molecule Drug Discovery Market Snippet by Region
  • 2.2. Competitive Insights

3. RNA Targeting Small Molecule Drug Discovery Key Market Trends

  • 3.1. RNA Targeting Small Molecule Drug Discovery Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. RNA Targeting Small Molecule Drug Discovery Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. RNA Targeting Small Molecule Drug Discovery Market Opportunities
  • 3.4. RNA Targeting Small Molecule Drug Discovery Market Future Trends

4. RNA Targeting Small Molecule Drug Discovery Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. RNA Targeting Small Molecule Drug Discovery Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. RNA Targeting Small Molecule Drug Discovery Market Landscape

  • 6.1. RNA Targeting Small Molecule Drug Discovery Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. RNA Targeting Small Molecule Drug Discovery Market - By Indication

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Indication, 2022&2030 (%)
    • 7.1.2. Neurological Diseases
    • 7.1.3. Cancer
    • 7.1.4. Metabolic Diseases
    • 7.1.5. Infectious Disease
    • 7.1.6. Others

8. RNA Targeting Small Molecule Drug Discovery Market - By Drug

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Drug, 2022&2030 (%)
    • 8.1.2. Tomivosertib
    • 8.1.3. Translarna™
    • 8.1.4. Risdiplam
    • 8.1.5. ELX-02
    • 8.1.6. ABX464
    • 8.1.7. H3B-6545

9. RNA Targeting Small Molecule Drug Discovery Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2022&2030 (%)
    • 9.1.2. Subcutaneous
    • 9.1.3. Oral

10. RNA Targeting Small Molecule Drug Discovery Market - By End-user

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-user, 2022&2030 (%)
    • 10.1.2. Academic and Research Institutes
    • 10.1.3. Pharmaceutical and Biopharmaceutical Companies
    • 10.1.4. Others

11. RNA Targeting Small Molecule Drug Discovery Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- RNA Targeting Small Molecule Drug Discovery Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. PTC Therapeutics
    • 12.2.2. Accent Therapeutics
    • 12.2.3. Expansion Therapeutics
    • 12.2.4. Anima Biotech Inc.
    • 12.2.5. Servier Laboratories
    • 12.2.6. Arrakis Therapeutics
    • 12.2.7. AstraZeneca
    • 12.2.8. Skyhawk Therapeutics, Inc.
    • 12.2.9. Epics Therapeutics
    • 12.2.10. H3 Biomedicine Inc.
    • 12.2.11. Hoffmann-La Roche Ltd
    • 12.2.12. Ribometrix
    • 12.2.13. AC immune
    • 12.2.14. STORM Therapeutics

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us